TY - JOUR
T1 - A Thoracic Surgeon-Directed Tobacco Cessation Intervention
AU - Kozower, Benjamin D.
AU - Lau, Christine L.
AU - Phillips, Jennifer V.
AU - Burks, Sandra G.
AU - Jones, David R.
AU - Stukenborg, George J.
N1 - Funding Information:
This study was funded by a grant from the American Cancer Society ( IRG 81-001-17 ). Doctor Kozower is also supported by the Agency for Healthcare Research and Quality ( K08-HS18049 ).
PY - 2010/3
Y1 - 2010/3
N2 - Background: Thoracic surgeons receive little training in promoting tobacco cessation despite the impact of tobacco use on their patients. There are only a few prospective reports of tobacco cessation efforts involving thoracic surgeons in the scientific literature. The purpose of this study was to prospectively evaluate a brief tobacco cessation intervention offered by surgeons in an outpatient thoracic surgery clinic. Methods: Adult smokers from a single-institution thoracic surgery clinic were enrolled in a single-arm prospective pilot trial between January and December 2008. Patients received a 10-minute intervention including discussing their motivation for quitting, offering tobacco cessation medication, and promoting a free telephone quitline. The primary outcome was abstinence at 3 months. Univariate logistic regression identified factors associated with tobacco cessation. Results: Forty of 60 eligible smokers enrolled in the study. The mean age and standard deviation of participants was 52.1 ± 12.6 years with a 39.9 ± 11.2 pack-year smoking history. The 3-month quit rate was 35% (14 of 40). Fifty percent (20 of 40) of participants used at least one tobacco cessation medication. Only 7.5% (3 of 40) of patients called the quitline, but each of these participants quit smoking. Successful tobacco cessation was associated with a malignant diagnosis and being the only tobacco user in the home (odds ratio, 4.2; 95% confidence interval, 1.0 to 17.2; and odds ratio, 6.1; 95% confidence interval, 1.4 to 26.3, respectively). Conclusions: Thoracic surgeons can successfully implement a tobacco cessation program with an excellent rate of abstinence compared with reported cessation rates at 3 months from the literature. Further investigation with a larger sample size, longer follow-up, and improved utilization of the quitline is warranted.
AB - Background: Thoracic surgeons receive little training in promoting tobacco cessation despite the impact of tobacco use on their patients. There are only a few prospective reports of tobacco cessation efforts involving thoracic surgeons in the scientific literature. The purpose of this study was to prospectively evaluate a brief tobacco cessation intervention offered by surgeons in an outpatient thoracic surgery clinic. Methods: Adult smokers from a single-institution thoracic surgery clinic were enrolled in a single-arm prospective pilot trial between January and December 2008. Patients received a 10-minute intervention including discussing their motivation for quitting, offering tobacco cessation medication, and promoting a free telephone quitline. The primary outcome was abstinence at 3 months. Univariate logistic regression identified factors associated with tobacco cessation. Results: Forty of 60 eligible smokers enrolled in the study. The mean age and standard deviation of participants was 52.1 ± 12.6 years with a 39.9 ± 11.2 pack-year smoking history. The 3-month quit rate was 35% (14 of 40). Fifty percent (20 of 40) of participants used at least one tobacco cessation medication. Only 7.5% (3 of 40) of patients called the quitline, but each of these participants quit smoking. Successful tobacco cessation was associated with a malignant diagnosis and being the only tobacco user in the home (odds ratio, 4.2; 95% confidence interval, 1.0 to 17.2; and odds ratio, 6.1; 95% confidence interval, 1.4 to 26.3, respectively). Conclusions: Thoracic surgeons can successfully implement a tobacco cessation program with an excellent rate of abstinence compared with reported cessation rates at 3 months from the literature. Further investigation with a larger sample size, longer follow-up, and improved utilization of the quitline is warranted.
UR - https://www.scopus.com/pages/publications/76749153382
U2 - 10.1016/j.athoracsur.2009.12.046
DO - 10.1016/j.athoracsur.2009.12.046
M3 - Article
C2 - 20172155
AN - SCOPUS:76749153382
SN - 0003-4975
VL - 89
SP - 926
EP - 930
JO - Annals of Thoracic Surgery
JF - Annals of Thoracic Surgery
IS - 3
ER -